Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genes encoding teleost orthologues of human signal transduction proteins remain duplicated or triplicated more frequently than the whole genome. | Heliyon | 2023 | 37809565 | PubTator, text mining | PubMed |
| Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways. | Front Immunol | 2023 | 37790926 | PubTator, text mining | PubMed |
| Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo. | Life Sci Alliance | 2023 | 37788908 | PubTator, text mining | PubMed |
| The unique 3D arrangement of macrophage galactose lectin enables Escherichia coli lipopolysaccharide recognition through two distinct interfaces. | PNAS Nexus | 2023 | 37780233 | PubTator, text mining | PubMed |
| Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs. | Nat Commun | 2023 | 37773180 | PubTator, text mining | PubMed |
| Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients. | Cancer Control | 2023 | 37771087 | PubTator, text mining | PubMed |
| On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI). | Eur J Pharm Sci | 2023 | 37770004 | PubTator, text mining | PubMed |
| M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice. | mBio | 2023 | 37768050 | PubTator, text mining | PubMed |
| Utility of In Vitro Cellular Models of Low-Dose Lipopolysaccharide in Elucidating the Mechanisms of Anti-Inflammatory and Wound-Healing-Promoting Effects of Lipopolysaccharide Administration In Vivo. | Int J Mol Sci | 2023 | 37762690 | PubTator, text mining | PubMed |
| Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment. | Int J Mol Sci | 2023 | 37762479 | PubTator, text mining | PubMed |
| High-Dose Vitamin B6 (Pyridoxine) Displays Strong Anti-Inflammatory Properties in Lipopolysaccharide-Stimulated Monocytes. | Biomedicines | 2023 | 37761018 | PubTator, text mining | PubMed |
| Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner. | Biomedicines | 2023 | 37760892 | PubTator, text mining | PubMed |
| Pyroptosis and inflammasomes in cancer and inflammation. | MedComm (2020) | 2023 | 37752941 | PubTator, text mining | PubMed |
| The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer. | Exp Hematol Oncol | 2023 | 37749607 | PubTator, text mining | PubMed |
| Editorial: Structural immunology of molecular innate immunity. | Front Immunol | 2023 | 37744327 | PubTator, text mining | PubMed |
| Embedding interpersonal stigma resistance into the medical curriculum: a focus group study of medical students. | BMC Med Educ | 2023 | 37735393 | PubTator, text mining | PubMed |
| Discovering immunoreceptor coupling and organization motifs. | Front Immunol | 2023 | 37731510 | PubTator, text mining | PubMed |
| Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity. | Front Immunol | 2023 | 37720208 | PubTator, text mining | PubMed |
| Toll-like receptor-immobilized carbon paste electrodes with plasma functionalized amine termination: Towards real-time electrochemical based triaging of gram-negative bacteria. | Biosens Bioelectron | 2023 | 37717423 | PubTator, text mining | PubMed |
| Association between Expanded Disability Status Scale score and dietary antioxidant capacity in patients with multiple sclerosis. | Braz J Med Biol Res | 2023 | 37703109 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=18